← Back to Search

Nicotine Replacement Therapy

Nicotine patch and lozenges for Tobacco Use

N/A
Waitlist Available
Led By Jennifer I Vidrine, PhD
Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 3 months
Awards & highlights

Study Summary

This trial will test a new smoking cessation and relapse prevention intervention for people with lung cancer.

Eligible Conditions
  • Tobacco Use
  • Lung Cancer
  • Smoking

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Completion rate of MAPS calls for UC+MAPS+RP participants - Demand
Percentage of Participants who meet inclusion criteria
Percentage of UC+MAPS+RP participants who viewed the web-based video -Demand
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group 2: Usual Care + Motivation and Problem Solving + Relapse PreventionExperimental Treatment4 Interventions
Participants will receive brief advice to quit, an offer of enrollment to the Florida Tobacco Quitline, and a 12 week supply of nicotine replacement therapy (nicotine patches and lozenges), 6 telephone counseling sessions over 6 months, and access to a web based video.
Group II: Group 1: Usual CareActive Control2 Interventions
Participants will receive brief advice to quit, an offer of enrollment to the Florida Tobacco Quitline, and a 12 week supply of nicotine replacement therapy (nicotine patches and lozenges).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Florida Tobacco Quitline
2021
N/A
~30
Nicotine
FDA approved
Telephone counseling sessions
2021
N/A
~30
Access to a web-based video
2021
N/A
~30

Find a Location

Who is running the clinical trial?

H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor
542 Previous Clinical Trials
135,471 Total Patients Enrolled
2 Trials studying Tobacco Use
269 Patients Enrolled for Tobacco Use
Jennifer I Vidrine, PhDPrincipal InvestigatorMoffitt Cancer Center
Vani N Simmons, PhDPrincipal InvestigatorMoffitt Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it still possible for volunteers to join this experiment?

"Indeed, this clinical trial is still open for recruitment. It was initially posted on June 7th 2021 and the latest update of its information occurred November 1st 2022."

Answered by AI

To what extent has recruitment for this clinical trial been successful?

"Affirmative. According to records on clinicaltrials.gov, this medical trial is open for enrollment; it was initially posted on June 7th 2021 and the most recent update occurred November 1st 2022. The experiment seeks 30 participants from a single site."

Answered by AI
~5 spots leftby Apr 2025